Overcoming time-varying confounding in self-controlled case series with active comparators: application and recommendations
American Journal of Epidemiology · 2025
DOI: 10.1093/aje/kwae216 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Epidemiology, 2025. Verfasst von Anna Schultze und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom. Hauptthemen laut MEDLINE: Pharmacoepidemiology. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GlaxoSmithKline.
Abstract (Originalsprache)
Confounding by indication is a key challenge for pharmacoepidemiologists. Although self-controlled study designs address time-invariant confounding, indications sometimes vary over time. For example, infection might act as a time-varying confounder in a study of antibiotics and uveitis, because it is time-limited and a direct cause of both receipt of antibiotics and uveitis. Methods for incorporating active comparators in self-controlled studies to address such time-varying confounding by indication have only recently been developed. In this paper, we formalize these methods and provide a detailed description for how the active comparator rate ratio can be derived in a self-controlled case series: either by explicitly comparing the regression coefficients for a drug of interest and an active comparator under certain circumstances using a simple ratio approach or through the use of a nested regression model. The approaches are compared in 2 case studies, one examining the association between thiazolidinedione use and fractures and one examining the association between fluoroquinolone use and uveitis, using the United Kingdom’s Clinical Practice Research Datalink. Finally, we provide recommendations for the use of these methods, which we hope will support the design, execution, and interpretation of self-controlled case series using active comparators and thereby increase the robustness of pharmacoepidemiologic studies. This article is part of a Special Collection on Pharmacoepidemiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom.
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, United States.
- GlaxoSmithKline PLC, London WC1A 1DG, United Kingdom.
- Analysis Group, London EC2R 7HJ, United Kingdom.
ORCID-Profile: Anna Schultze, Jeremy Brown, John Logie, Marianne Cunnington, Gema Requena, Iain A Gillespie, Stephen J W Evans, Ian Douglas, Nicholas Galwey
Förderung
- GlaxoSmithKline
Zitieren
APA
Schultze, A., Brown, J., Logie, J., Cunnington, M., Requena, G., Gillespie, I. A., Evans, S. J. W., Douglas, I., & Galwey, N. (2025). Overcoming time-varying confounding in self-controlled case series with active comparators: application and recommendations. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwae216
Vancouver
Schultze A, Brown J, Logie J, Cunnington M, Requena G, Gillespie IA, et al. Overcoming time-varying confounding in self-controlled case series with active comparators: application and recommendations. American Journal of Epidemiology. 2025. doi:10.1093/aje/kwae216
BibTeX
@article{Schultze2025,
author = {Schultze, Anna and Brown, Jeremy and Logie, John and Cunnington, Marianne and Requena, Gema and Gillespie, Iain A and Evans, Stephen J W and Douglas, Ian and Galwey, Nicholas},
title = {Overcoming time-varying confounding in self-controlled case series with active comparators: application and recommendations},
journal = {American Journal of Epidemiology},
year = {2025},
doi = {10.1093/aje/kwae216}
}
EUVIMED